Position history for Capital Research Global Investors's holdings in VERTEX PHARMACEUTICALS INC
Capital Research Global Investors holds 21.1M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $9.4B as of 2026-Q1. The position was increased (+22.0% shares). VRTX represents 1.5% of Capital Research Global Investors's portfolio.
Current Value
$9.4B
Current Shares
21.1M
Total Value Change
+$5.4B
Total Shares Change
+12.6M
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 21.1M |
+22.0% |
| $9.4B |
| 1.5% |
| $474.27 |
60 |
| 2025-Q4 | Increased | 17.3M | +4.6% | $7.9B | 1.4% | $453.74 | 53 |
| 2025-Q3 | Increased | 16.6M | +2.8% | $6.5B | 1.2% | $395.31 | 52 |
| 2025-Q2 | Increased | 16.1M | +10.8% | $7.2B | 1.4% | $441.30 | 56 |
| 2025-Q1 | Increased | 14.5M | +39.4% | $7B | 1.5% | $492.69 | 66 |
| 2024-Q4 | Increased | 10.4M | +15.8% | $4.2B | 0.9% | $399.35 | 52 |
| 2024-Q3 | Increased | 9M | +5.4% | $4.2B | 0.9% | $462.88 | 47 |
| 2024-Q2 | Increased | 8.5M | +48.7% | $4B | 0.9% | $468.72 | 62 |